Principal Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Sell
2,505
-36
-1% -$23.1K 0.02% 614
2025
Q4
$1.72M Buy
2,541
+345
+16% +$235K 0.03% 527
2025
Q3
$1.4M Buy
2,196
+118
+6% +$71.6K 0.02% 551
2025
Q2
$1.11M Buy
2,078
+1,387
+201% +$663K 0.02% 583
2025
Q1
$286K Hold
691
0.01% 998
2024
Q4
$286K Sell
691
-345
-33% -$151K 0.01% 995
2024
Q3
$523K Sell
1,036
-734
-41% -$357K 0.01% 745
2024
Q2
$862K Buy
1,770
+30
+2% +$15.1K 0.02% 514
2024
Q1
$939K Buy
1,740
+163
+10% +$89.1K 0.03% 473
2023
Q4
$875K Buy
+1,577
New +$740K 0.03% 451

Other funds holding IDXX

Principal Securities's IDXX Position: Q1 2026 in Review

Principal Securities reduced its Idexx Laboratories (IDXX) stake by 1.4% in Q1 2026, selling an estimated $23.1K and leaving 2,505 shares worth $1.41M. The position accounts for 0.02% of the portfolio, ranked #614.

Principal Securities first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.72M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Principal Securities held 2,505 shares of Idexx Laboratories worth $1.41M as of Q1 2026.
  • Principal Securities sold 36 Idexx Laboratories shares in Q1 2026, an estimated $23.1K.
  • Idexx Laboratories made up 0.02% of Principal Securities's portfolio in Q1 2026, its #614 holding.
  • Principal Securities first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
  • Principal Securities's Idexx Laboratories position peaked at $1.72M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.